Table 1.
Means and standard deviations on outcome measures for collapsed treatment and control groups from baseline to 3-year follow-up
| Group | Parent SCARED | Parent MASC | Child MASC | Parent CSR | Child CSR |
|---|---|---|---|---|---|
| Baseline | |||||
| Treatment (n = 37) | 25.06 (13.38) | 51.92 (16.56) | 52.68 (8.42) | 3.24 (1.64) | 3.68 (1.87) |
| Control (n = 24) | 21.25 (9.64) | 50.46 (12.62) | 51.29 (10.08) | 3.29 (1.60) | 2.96 (2.18) |
| Posttreatment | |||||
| Treatment (n = 37) | 16.62 (9.99) | 44.54 (17.66) | 51.56 (11.25) | 2.05 (1.76) | 1.57 (1.71) |
| Control (n = 24) | 21.04 (10.80) | 53.00 (12.70) | 49.08 (10.50) | 2.58 (2.08) | 2.13 (1.92) |
| 3-month follow-up | |||||
| Treatment (n = 27) | 14.60 (11.68) | 40.72 (18.53) | 46.32 (11.19) | -- | -- |
| Control (n = 24) | 19.04 (12.13) | 47.42 (13.82) | 50.58 (8.77) | -- | -- |
| 6-month follow-up | |||||
| Treatment (n = 31) | 14.23 (10.04) | 40.73 (15.99) | 46.77 (9.96) | 1.29 (1.75) | 0.81 (1.40) |
| Control (n = 23) | 18.86 (12.81) | 49.82 (15.24) | 47.23 (11.49) | 2.43 (2.11) | 0.77 (1.41) |
| 1-year follow-up | |||||
| Treatment (n = 29) | 14.21 (9.41) | 41.89 (15.81) | 45.64 (8.66) | 0.79 (1.24) | 0.24 (0.83) |
| Control (n = 10)a | 23.20 (11.71) | 54.22 (14.51) | 48.00 (9.57) | 1.80 (1.87) | 0.56 (1.33) |
| 2-year follow-up | |||||
| Treatment (n = 26) | 13.44 (7.96) | 42.56 (12.54) | 47.24 (14.01) | 1.69 (2.17) | 0.77 (1.56) |
| Control (n = 8)a | 20.50 (8.18) | 50.50 (8.78) | 55.25 (13.52) | 2.63 (2.77) | 0.75 (1.39) |
| 3-year follow-up | |||||
| Treatment (n = 22) | 12.75 (11.07) | 37.50 (16.13) | 48.42 (14.11) | 0.86 (1.42) | 1.05 (1.86) |
| Control (n = 9)a | 16.29 (8.98) | 49.67 (17.30) | 48.63 (13.16) | 1.89 (2.26) | 1.89 (2.67) |
a
1-, 2-, and 3-year follow-up data from 12 control participants who received treatment after 6-month posttreatment were excluded from analyses.